S1PR1 and breast neoplasm: Here we demonstrate that in naive and breast tumor‐bearing immunocompetent mice, a clinically relevant dose of FTY720/Fingolimod that targets sphingosine‐1‐phosphate receptor 1 (S1PR1), alleviated paclitaxel‐induced neuropathic pain.